National Bank of Canada’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History
Bought
Maintained
Sold
Other funds holding NBP
HA
CC
OCA
National Bank of Canada's NBP Position: Q1 2022 in Review
National Bank of Canada sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 289,300 shares — an estimated $13.7M sold.
National Bank of Canada first reported a position in NBP in Q4 2021 and held it in 1 quarter. The position peaked at $13.7M in Q4 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.
- National Bank of Canada reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
- National Bank of Canada sold 289,300 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $13.7M.
- National Bank of Canada first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 1 quarter.
- National Bank of Canada's NovaBridge Biosciences American Depositary Shares position peaked at $13.7M in Q4 2021.
- 120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.
Based on National Bank of Canada's 13F filing for Q1 2022, filed 5 May 2022.